Agios Pharmaceuticals AGIO
NASDAQ AGIO
$33.25 -0.05 (-0.15%)
At close: Sep 30, 2026 · 4:00 PM EDT

Agios Pharmaceuticals (AGIO) EV to CFO (2016)

Updated

Agios Pharmaceuticals' (AGIO) EV to CFO was 31.65 for Q4 2016, up 14.4% from the prior quarter.

Analysis

Agios Pharmaceuticals (AGIO) EV to CFO (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Agios Pharmaceuticals 1.98 Bn 1.98 Bn 41.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 31.65
Sep 30, 2016 27.68
Jun 30, 2016 13.51
API Access

Agios Pharmaceuticals EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=AGIO&period=max&api_key=YOUR_API_KEY